Max Healthcare Institute Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,569 Cr +20.3% YoYSee revenue, profit and what management said. You are viewing Q4 FY25.
MH

Max Healthcare Institute Ltd

Q4 FY25Healthcare Services

Max Healthcare Institute Q4 FY25 earnings call: Revenue & Margins

Q4 FY25 earnings call: what management said on revenue, margins and capex.

Revenue
₹1,910Cr
+34.2% YoY
+2.2% QoQ
Net profit
₹319Cr
+26.6% YoY
+33.5% QoQ
Margin
27%
0 pp YoY
0 pp QoQ
Price₹1,000
Market cap₹98.2K Cr
P/E65.6

The short version

Max Healthcare expects strong growth driven by recent acquisitions (Lucknow, Nagpur, Jaypee Noida) and new facilities (Dwarka, brownfield expansions). Strong earnings and EBITDA growth expected driven by capacity expansion and acquisitions.

From Max Healthcare Institute Ltd's Q4 FY25 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Max Healthcare expects strong growth driven by recent acquisitions (Lucknow, Nagpur, Jaypee Noida) and new facilities (Dwarka, brownfield expansions).
  • FY '25 revenue saw a 26% YoY growth and 22% growth in EBITDA.
  • New brownfield expansions adding around 1,500 beds in FY '26 are expected to ramp up quickly, improving occupancy and margins.
  • Greenfield projects like Gurgaon will take longer to mature but contribute incremental revenue over time.
  • Average Revenue Per Occupied Bed (ARPOB) is growing (~7% YoY growth in existing hospitals).
  • Increased institutional and international business will contribute, though international patients may not move the needle significantly at new locations initially.

2 more points from Max Healthcare Institute Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Max Healthcare Institute Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Max Healthcare is undertaking multiple expansion projects:
  • 268 beds at Nanavati (Phase I) with commissioning expected within 90 days.
  • 155 beds at Mohali with commissioning also expected within 90 days; plans to add 45 more beds post-tower completion.
  • A built-to-suit hospital in Gurgaon (Sec-56) to be completed by end of calendar year.
  • Brownfield expansions at Max Smart and other locations adding approximately 1,500 beds in FY '26.
  • 18 acres of land in Noida with potential to add 1,000+ beds; current occupancy at 50%.
  • Land acquisition of around 1 acre adjacent to fully occupied Vaishali hospital; brownfield expansion expected within 30 months.

2 more points from Max Healthcare Institute Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Max Healthcare Institute Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • It does detail ongoing and upcoming expansion projects including:
  • 397 beds at Patparganj with environmental clearance and tendering underway.
  • 550 beds at Max Vikrant (Saket Complex) pending forest department clearance, expected completion by 2028.
  • 400 beds at Zirakpur (Mohali), awaiting environmental clearance, with a 30-month completion timeline.
  • 140 beds at Vaishali brownfield project planned, expected completion within 30 months.
  • The company plans to add around 1,500 beds in FY26 through brownfield expansions and greenfield projects like Nanavati (268 beds), Mohali (155 beds), Max Smart, and Gurgaon Sec-56.

2 more points from Max Healthcare Institute Ltd's call on order book

Create a free account to keep reading this call

Max Healthcare Institute Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Max Healthcare Institute Ltd Q4 FY25 results — key figures

Max Healthcare Institute Ltd Q4 FY25 reported results vs Q4 FY24, ₹ crore
₹ CrQ4 FY25Q4 FY24YoYQ3 FY25QoQ
Revenue1,9101,423+34.2%1,868+2.2%
Operating profit (EBITDA)512382+34%499+2.6%
Operating margin27%27%0 pp27%0 pp
Profit before tax402336+19.6%309+30.1%
Net profit (PAT)319252+26.6%239+33.5%
EPS (₹)3.282.59+26.6%2.46+33.3%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.6K Cr, net profit ₹414 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • 3B Blackbio (Q4 FY25)

    UK subsidiary (TRUPCR Europe Limited) revenue FY 2024-25: GBP 1,287,580, a 94% increase over FY 2023-24 GBP 664,059. Key concall takeaways from 3B Blackbio DX…

  • Apollo Hospitals (Q4 FY25)

    . Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q4 FY25 earnings call — and how it ranks against sector peers.

  • Shalby (Q4 FY25)

    Implant business is in high-growth mode: 4x growth in Indonesia, 35-40% growth in U.S., and 2.5x growth in India reported last year. Key concall takeaways from…

  • Narayana Hrudaya (Q4 FY25)

    Capex is split between regular maintenance/replacement (~INR 300 crores) and new greenfield/brownfield capacity (~INR 450 crores) with some variability based…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Max Healthcare Institute Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Max Healthcare Institute Ltd Q4 FY25 results?

Max Healthcare expects strong growth driven by recent acquisitions (Lucknow, Nagpur, Jaypee Noida) and new facilities (Dwarka, brownfield expansions). Strong earnings and EBITDA growth expected driven by capacity expansion and acquisitions.

What is Max Healthcare Institute Ltd share price analysis?

Max Healthcare Institute Ltd currently shows a neutral. The stock trades at a P/E of 65.6 with a market cap of ₹98,161 Cr. Investors should review the full earnings analysis for detailed insights.

Is Max Healthcare Institute Ltd planning capital expenditure?

Max Healthcare is undertaking multiple expansion projects: - 268 beds at Nanavati (Phase I) with commissioning expected within 90 days.

Keep Max Healthcare Institute Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.